EVLV Stock Analysis: Evolv Technologies Holdings | NASDAQ
Security & Protection Services | NASDAQ, USA | Market Cap: 1.104m USD | 12M Return: 2.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.2M
Qual. Beats: 0
Rev. Trend: 98.8%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) develops and sells AI-based physical security screening systems designed to detect weapons and threats in high-traffic venues. Its flagship product, Evolv Express, uses sensor-based technology to screen people for firearms, improvised explosive devices, and large tactical knives without requiring them to stop or empty their pockets, while Evolv eXpedite extends similar detection capabilities to bags in cluttered environments. The company complements its hardware with Evolv Insights, a cloud-based analytics platform that provides venue operators with data on visitor flow, detection performance, and alarm statistics, indicating a recurring software/SaaS component layered on top of its equipment sales.
The company serves a diverse customer base across education, healthcare, professional sports, performing arts and entertainment venues, tourist destinations, government and corporate offices, hospitality, industrial workplaces, distribution facilities, and houses of worship. This broad vertical exposure positions Evolv within the broader physical security and electronic equipment industry, competing in a market traditionally served by walk-through metal detectors and X-ray systems, where AI-driven, touchless screening is increasingly seen as an alternative for venues seeking higher throughput. Founded in 2013 and headquartered in Waltham, Massachusetts, Evolv went public in September 2020 and operates as a small-cap information technology company classified under electronic equipment and instruments.
- Federal school safety funding boosts education vertical demand
- Competitive pricing pressures gross margin trajectory
- Venue and government contract wins diversify revenue mix
| Net Income: -36.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA 14.27 > 1.0 |
| NWC/Revenue: 16.30% < 20% (prev 8.22%; Δ 8.08% < -1%) |
| CFO/TA 0.06 > 3% & CFO 18.0m > Net Income -36.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (177.1m) vs 12m ago 10.10% < -2% |
| Gross Margin: 49.90% > 18% (prev 58.04%; Δ -8.14% > 0.5%) |
| Asset Turnover: 57.16% > 50% (prev 44.54%; Δ 12.62% > 0%) |
| Interest Coverage Ratio: -12.55 > 6 (EBIT TTM -33.8m / Interest Expense TTM 2.69m) |
| A: 0.09 (Total Current Assets 152.0m - Total Current Liabilities 125.9m) / Total Assets 304.6m |
| B: -1.29 (Retained Earnings -392.8m / Total Assets 304.6m) |
| C: -0.12 (EBIT TTM -33.8m / Avg Total Assets 280.3m) |
| D: 0.66 (Book Value of Equity 120.7m / Total Liabilities 184.0m) |
| Altman-Z'' = -3.76 = D |
| DSRI: 0.88 (Receivables 43.9m/35.4m, Revenue 160.2m/114.0m) |
| GMI: 1.16 (GM 58.04% / 49.90%) |
| AQI: 1.21 (AQ_t 0.04 / AQ_t-1 0.04) |
| SGI: 1.41 (Revenue 160.2m / 114.0m) |
| TATA: -0.18 (NI -36.5m - CFO 18.0m) / TA 304.6m) |
| Beneish M = -2.58 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 6.05 with a total of 1,807,654 shares traded. Over the past week, the price has changed by +4.31%, over one month by +3.95%, over three months by -0.98% and over the past year by +2.37%.
Current recommended Stop Loss: 5.40 (which is 10.7% or 2 ATR below the current price).
Evolv Technologies Holdings has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy EVLV.
- StrongBuy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 10.1 | 67.4% |
P/E Forward = 43.29
P/S = 6.8928
P/B = 9.3011
Revenue TTM = 160.2m USD
EBIT TTM = -33.8m USD
EBITDA TTM = -8.19m USD
Long Term Debt = 28.7m USD (from longTermDebt, last quarter)
Short Term Debt = 3.12m USD (from shortTermDebt, last quarter)
Debt = 55.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 13.3m
Net Debt = -5.80m USD (calculated: Debt 55.3m - CCE 61.1m)
Enterprise Value = 1.10b USD (1.10b + Debt 55.3m - CCE 61.1m)
Interest Coverage Ratio = -12.55 (Ebit TTM -33.8m / Interest Expense TTM 2.69m)
EV/FCF = -84.53x (Enterprise Value 1.10b / FCF TTM -13.0m)
FCF Yield = -1.18% (FCF TTM -13.0m / Enterprise Value 1.10b)
FCF Margin = -8.11% (FCF TTM -13.0m / Revenue TTM 160.2m)
Net Margin = -22.75% (Net Income TTM -36.5m / Revenue TTM 160.2m)
Gross Margin = 49.90% ((Revenue TTM 160.2m - Cost of Revenue TTM 80.3m) / Revenue TTM)
Gross Margin QoQ = 51.37% (prev 48.38%)
Tobins Q-Ratio = 3.61 (Enterprise Value 1.10b / Total Assets 304.6m)
Interest Expense / Debt = 4.87% (Interest Expense 2.69m / Debt 55.3m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -26.7m (EBIT -33.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.21 (Total Current Assets 152.0m / Total Current Liabilities 125.9m)
Debt / Equity = 0.46 (Debt 55.3m / totalStockholderEquity, last quarter 120.7m)
Debt / EBITDA = 0.71 (negative EBITDA) (Net Debt -5.80m / EBITDA -8.19m)
Debt / FCF = 0.45 (negative FCF - burning cash) (Net Debt -5.80m / FCF TTM -13.0m)
Total Stockholder Equity = 108.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -13.01% (Net Income -36.5m / Total Assets 304.6m)
RoE = -33.53% (Net Income TTM -36.5m / Total Stockholder Equity 108.7m)
RoCE = -24.60% (EBIT -33.8m / Capital Employed (Equity 108.7m + L.T.Debt 28.7m))
RoIC = -15.36% (negative operating profit) (NOPAT -26.7m / Invested Capital 173.9m)
WACC = 11.06% (E(1.10b)/V(1.16b) * Re(11.42%) + D(55.3m)/V(1.16b) * Rd(4.87%) * (1-Tc(0.21)))
Discount Rate = 11.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 77.78 | Cagr: 7.30%
[DCF] Fair Price = unknown (Cash Flow -13.0m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.36 | # QB: 0
Revenue Correlation: 98.81 | Revenue CAGR: 32.31% | SUE: 0.90 | # QB: 1
EPS current Quarter (2026-03-31): EPS=-0.02 | Chg30d=N/A | Revisions=+0% | Analysts=3
EPS next Quarter (2026-06-30): EPS=-0.02 | Chg30d=N/A | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=-0.06 | Chg30d=+5.10% | Revisions=-25% | GrowthEPS=+36.7% | GrowthRev=+21.4%
EPS next Year (2027-12-31): EPS=-0.03 | Chg30d=N/A | Revisions=-25% | GrowthEPS=+52.6% | GrowthRev=+18.1%
[Analyst] Revisions Ratio: -22% (up=2, down=4)